Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer

This study has been completed.

Study NCT00034151 Information provided by OncoGenex Pharmaceuticals

First Received: April 23, 2002 Last Updated: June 2, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2007
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)